{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T23:19:24Z","timestamp":1778282364464,"version":"3.51.4"},"reference-count":34,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"NIH","award":["R21 HL097298 and R44 HL104885"],"award-info":[{"award-number":["R21 HL097298 and R44 HL104885"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.thromres.2012.09.017","type":"journal-article","created":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T20:00:16Z","timestamp":1349121616000},"page":"89-93","source":"Crossref","is-referenced-by-count":29,"title":["Differential regulation of fibrinogen \u03b3 chain splice isoforms by interleukin-6"],"prefix":"10.1016","volume":"131","author":[{"given":"Chantelle M.","family":"Rein-Smith","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathan W.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David H.","family":"Farrell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2012.09.017_bb0005","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1055\/s-0037-1613148","article-title":"Association of \u03b3A\/\u03b3' fibrinogen levels and coronary artery disease","volume":"88","author":"Lovely","year":"2002","journal-title":"Thromb Haemost"},{"issue":"S1","key":"10.1016\/j.thromres.2012.09.017_bb0010","first-page":"128","article-title":"Plasma \u03b3'\/\u03b3 fibrinogen ratio, a marker of arterial thrombotic activity : A new potential cardiovascular risk factor?","volume":"10","author":"Drouet","year":"1999","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.thromres.2012.09.017_bb0015","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1111\/j.1538-7836.2007.02406.x","article-title":"Elevated plasma fibrinogen \u03b3' concentration is associated with myocardial infarction: Effects of variation in fibrinogen genes and environmental factors","volume":"5","author":"Mannila","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2012.09.017_bb0020","doi-asserted-by":"crossref","first-page":"4603","DOI":"10.1182\/blood-2009-08-236240","article-title":"Elevated fibrinogen \u03b3' ratio is associated with cardiovascular diseases and acute phase reaction but not with clinical outcome","volume":"114","author":"Cheung","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2012.09.017_bb0025","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1161\/STROKEAHA.107.495499","article-title":"Fibrinogen \u03b3' in ischemic stroke: A case\u2013control study","volume":"39","author":"Cheung","year":"2008","journal-title":"Stroke"},{"key":"10.1016\/j.thromres.2012.09.017_bb0030","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1160\/TH10-09-0626","article-title":"Association between \u03b3' fibrinogen levels and inflammation","volume":"105","author":"Alexander","year":"2011","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2012.09.017_bb0035","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1016\/j.jacc.2009.09.009","article-title":"Leducq Transatlantic Network on Atherothrombosis. Inflammation in atherosclerosis: from pathophysiology to practice","volume":"54","author":"Libby","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.thromres.2012.09.017_bb0040","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1373\/clinchem.2009.138347","article-title":"\u03b3' fibrinogen: evaluation of a new assay for study of associations with cardiovascular disease","volume":"56","author":"Lovely","year":"2010","journal-title":"Clin Chem"},{"key":"10.1016\/j.thromres.2012.09.017_bb0045","doi-asserted-by":"crossref","first-page":"4232","DOI":"10.1021\/bi00313a033","article-title":"\u03b3 and \u03b3' chains of human fibrinogen are produced by alternative mRNA processing","volume":"23","author":"Chung","year":"1984","journal-title":"Biochemistry"},{"key":"10.1016\/j.thromres.2012.09.017_bb0050","doi-asserted-by":"crossref","first-page":"12826","DOI":"10.1016\/S0021-9258(18)90821-5","article-title":"Structure of the human \u03b3-fibrinogen gene. alternate mRNA splicing near the 3' end of the gene produces \u03b3A and \u03b3B forms of \u03b3-fibrinogen","volume":"259","author":"Fornace","year":"1984","journal-title":"J Biol Chem"},{"key":"10.1016\/j.thromres.2012.09.017_bb0055","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1161\/01.ATV.0000109748.77727.3e","article-title":"Influence of \u03b3' fibrinogen splice variant on fibrin physical properties and fibrinolysis rate","volume":"24","author":"Collet","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.thromres.2012.09.017_bb0060","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1126\/science.6248960","article-title":"Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen","volume":"209","author":"Knowles","year":"1980","journal-title":"Science"},{"key":"10.1016\/j.thromres.2012.09.017_bb0065","doi-asserted-by":"crossref","first-page":"9414","DOI":"10.1021\/bi00103a004","article-title":"Recombinant human fibrinogen and sulfation of the \u03b3' chain","volume":"30","author":"Farrell","year":"1991","journal-title":"Biochemistry"},{"key":"10.1016\/j.thromres.2012.09.017_bb0070","doi-asserted-by":"crossref","first-page":"3032","DOI":"10.4049\/jimmunol.146.9.3032","article-title":"Effects of cytokine combinations on acute phase protein production in two human hepatoma cell lines","volume":"146","author":"Mackiewicz","year":"1991","journal-title":"J Immunol"},{"key":"10.1016\/j.thromres.2012.09.017_bb0075","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1365-2141.1987.tb02326.x","article-title":"Interleukin 1 or endotoxin increases the release of von Willebrand factor from human endothelial cells","volume":"67","author":"Schorer","year":"1987","journal-title":"Br J Haematol"},{"key":"10.1016\/j.thromres.2012.09.017_bb0080","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1084\/jem.163.6.1595","article-title":"Interleukin 1 induces endothelial cell synthesis of plasminogen activator inhibitor","volume":"163","author":"Nachman","year":"1986","journal-title":"J Exp Med"},{"key":"10.1016\/j.thromres.2012.09.017_bb0085","doi-asserted-by":"crossref","first-page":"3460","DOI":"10.1073\/pnas.83.10.3460","article-title":"Interleukin 1 induces endothelial cell procoagulant while suppressing cell-surface anticoagulant activity","volume":"83","author":"Nawroth","year":"1986","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.thromres.2012.09.017_bb0090","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1182\/blood-2004-01-0126","article-title":"Interleukin-1\u03b2 but not interleukin-1\u03b1 binds to fibrinogen and fibrin and has enhanced activity in the bound form","volume":"104","author":"Sahni","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2012.09.017_bb0095","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.cardiores.2007.02.022","article-title":"TGF-\u03b2 and atherosclerosis in man","volume":"74","author":"Grainger","year":"2007","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.thromres.2012.09.017_bb0100","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1055\/s-0038-1648474","article-title":"Transforming growth factor \u03b2 (TGF-\u03b2) inhibits expression of fibrinogen and factor VII in a hepatoma cell line","volume":"67","author":"Hassan","year":"1992","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2012.09.017_bb0105","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1073\/pnas.87.4.1491","article-title":"Transforming growth factor \u03b21 regulates production of acute-phase proteins","volume":"87","author":"Mackiewicz","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.thromres.2012.09.017_bb0110","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1128\/IAI.58.9.2750-2754.1990","article-title":"Tumor necrosis factor (TNF) is induced in mice by Candida albicans: Role of TNF in fibrinogen increase","volume":"58","author":"Riipi","year":"1990","journal-title":"Infect Immun"},{"key":"10.1016\/j.thromres.2012.09.017_bb0115","doi-asserted-by":"crossref","first-page":"41270","DOI":"10.1074\/jbc.M304210200","article-title":"Functional analysis of interleukin 6 response elements (IL-6REs) on the human \u03b3-fibrinogen promoter","volume":"278","author":"Duan","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.thromres.2012.09.017_bb0120","doi-asserted-by":"crossref","first-page":"24287","DOI":"10.1074\/jbc.270.41.24287","article-title":"Characterization of the IL-6 responsive elements in the \u03b3 fibrinogen gene promoter","volume":"270","author":"Zhang","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/j.thromres.2012.09.017_bb0125","doi-asserted-by":"crossref","first-page":"3994","DOI":"10.1182\/blood-2009-05-217968","article-title":"The pleiotropic role of the fibrinogen \u03b3' chain in hemostasis","volume":"114","author":"Uitte de Willige","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2012.09.017_bb0130","doi-asserted-by":"crossref","unstructured":"Farrell DH. \u03b3' fibrinogen as a novel marker of thrombotic disease. Clin Chem Lab Med in press.","DOI":"10.1515\/cclm-2012-0005"},{"key":"10.1016\/j.thromres.2012.09.017_bb0135","doi-asserted-by":"crossref","first-page":"3466","DOI":"10.1182\/blood.V96.10.3466","article-title":"Interleukin 1\u03b2 inhibits interleukin 6-mediated rat \u03b3 fibrinogen gene expression","volume":"96","author":"Zhang","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2012.09.017_bb0140","doi-asserted-by":"crossref","first-page":"28350","DOI":"10.1074\/jbc.270.47.28350","article-title":"Characterization of the 5'-flanking region of the gene for the \u03b3 chain of human fibrinogen","volume":"270","author":"Mizuguchi","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/j.thromres.2012.09.017_bb0145","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/nature01153","article-title":"Signal-dependent regulation of splicing via phosphorylation of Sam68","volume":"420","author":"Matter","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.thromres.2012.09.017_bb0150","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/sj.cr.7290250","article-title":"Regulation of alternative splicing of Bcl-x by IL-6, GM-CSF and TPA","volume":"14","author":"Li","year":"2004","journal-title":"Cell Res"},{"key":"10.1016\/j.thromres.2012.09.017_bb0155","doi-asserted-by":"crossref","first-page":"4194","DOI":"10.1093\/emboj\/20.15.4194","article-title":"Regulation of alternative pre-mRNA splicing by the ERK MAP-kinase pathway","volume":"20","author":"Weg-Remers","year":"2001","journal-title":"EMBO J"},{"key":"10.1016\/j.thromres.2012.09.017_bb0160","doi-asserted-by":"crossref","first-page":"5326","DOI":"10.1128\/MCB.19.8.5326","article-title":"Dual signaling role of the protein tyrosine phosphatase SHP-2 in regulating expression of acute-phase plasma proteins by interleukin-6 cytokine receptors in hepatic cells","volume":"19","author":"Kim","year":"1999","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.thromres.2012.09.017_bb0165","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.freeradbiomed.2009.10.045","article-title":"Oxidants induce alternative splicing of alpha-synuclein: Implications for Parkinson's Disease","volume":"48","author":"Kalivendi","year":"2010","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.thromres.2012.09.017_bb0170","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1186\/1471-2407-8-260","article-title":"MAP kinase pathways and calcitonin influence CD44 alternate isoform expression in prostate cancer cells","volume":"8","author":"Robbins","year":"2008","journal-title":"BMC Cancer"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384812007529?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384812007529?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T01:10:52Z","timestamp":1687741852000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384812007529"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S0049384812007529"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2012.09.017","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}